Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Diabetes and cognitive deficits in chronic schizophrenia: a case-control study.

Han M, Huang XF, Chen da C, Xiu M, Kosten TR, Zhang XY.

PLoS One. 2013 Jun 20;8(6):e66299. doi: 10.1371/journal.pone.0066299. Print 2013.

2.

Gender differences in cognitive function of patients with chronic schizophrenia.

Han M, Huang XF, Chen da C, Xiu MH, Hui L, Liu H, Kosten TR, Zhang XY.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):358-63. doi: 10.1016/j.pnpbp.2012.07.010. Epub 2012 Jul 20.

PMID:
22820676
3.

Tardive dyskinesia is associated with greater cognitive impairment in schizophrenia.

Wu JQ, Chen da C, Xiu MH, Tan YL, Yang FD, Kosten TR, Zhang XY.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:71-7. doi: 10.1016/j.pnpbp.2013.06.013. Epub 2013 Jul 1.

PMID:
23827756
4.

Cognitive differences in schizophrenia on long-term treatments with clozapine, risperidone and typical antipsychotics.

Han M, Zhang XY, Chen da C, Tan YL, Song CS, Yu YH, Huang XF.

Int Clin Psychopharmacol. 2015 Mar;30(2):89-95. doi: 10.1097/YIC.0000000000000066.

PMID:
25568968
5.

Plasma total antioxidant status and cognitive impairments in schizophrenia.

Zhang XY, Chen da C, Xiu MH, Tang W, Zhang F, Liu L, Chen Y, Liu J, Yao JK, Kosten TA, Kosten TR.

Schizophr Res. 2012 Aug;139(1-3):66-72. doi: 10.1016/j.schres.2012.04.009. Epub 2012 May 1.

PMID:
22555016
6.

Cigarette smoking and cognitive function in Chinese male schizophrenia: a case-control study.

Zhang XY, Chen da C, Xiu MH, Haile CN, Sun H, Lu L, Kosten TA, Kosten TR.

PLoS One. 2012;7(5):e36563. doi: 10.1371/journal.pone.0036563. Epub 2012 May 3.

7.

Clinical symptoms and cognitive impairment associated with male schizophrenia relate to plasma manganese superoxide dismutase activity: a case-control study.

Zhang XY, Chen da C, Xiu MH, Tan YL, Yang FD, Zhang LY, Zhang LY, Haile CN, Kosten TR.

J Psychiatr Res. 2013 Aug;47(8):1049-53. doi: 10.1016/j.jpsychires.2013.03.014. Epub 2013 Apr 20.

PMID:
23611682
8.

Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia.

Zhang XY, Liang J, Chen da C, Xiu MH, Yang FD, Kosten TA, Kosten TR.

Psychopharmacology (Berl). 2012 Jul;222(2):277-84. doi: 10.1007/s00213-012-2643-y. Epub 2012 Jan 26.

PMID:
22274000
9.

Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results.

Dittmann S, Seemüller F, Schwarz MJ, Kleindienst N, Stampfer R, Zach J, Born C, Bernhard B, Fast K, Grunze H, Engel RR, Severus E.

Bipolar Disord. 2007 Feb-Mar;9(1-2):63-70.

PMID:
17391351
10.

Gender differences in never-medicated first-episode schizophrenia and medicated chronic schizophrenia patients.

Zhang XY, Chen da C, Xiu MH, Yang FD, Haile CN, Kosten TA, Kosten TR.

J Clin Psychiatry. 2012 Jul;73(7):1025-33. doi: 10.4088/JCP.11m07422.

PMID:
22901352
11.

[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].

Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.

Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. French.

PMID:
19081451
12.

Interleukin 18 and cognitive impairment in first episode and drug naïve schizophrenia versus healthy controls.

Zhang XY, Tang W, Xiu MH, Chen da C, Yang FD, Tan YL, Wang ZR, Zhang F, Liu J, Liu L, Chen Y, Wen N, Kosten TR.

Brain Behav Immun. 2013 Aug;32:105-11. doi: 10.1016/j.bbi.2013.03.001. Epub 2013 Mar 14.

PMID:
23499732
13.
14.

Thioredoxin, a novel oxidative stress marker and cognitive performance in chronic and medicated schizophrenia versus healthy controls.

Zhang XY, Chen da C, Xiu MH, Yang FD, Tan YL, He S, Kosten TA, Kosten TR.

Schizophr Res. 2013 Feb;143(2-3):301-6. doi: 10.1016/j.schres.2012.11.017. Epub 2012 Dec 11.

PMID:
23238053
15.

Cognition impairment in schizophrenia patients with tardive dyskinesia: association with plasma superoxide dismutase activity.

Wu JQ, Chen da C, Tan YL, Tan SP, Wang ZR, Xiu MH, Yang FD, Zhang XY.

Schizophr Res. 2014 Jan;152(1):210-6. doi: 10.1016/j.schres.2013.11.010. Epub 2013 Dec 8.

PMID:
24325977
16.

Diabetes is associated with lower global cognitive function in schizophrenia.

Takayanagi Y, Cascella NG, Sawa A, Eaton WW.

Schizophr Res. 2012 Dec;142(1-3):183-7. doi: 10.1016/j.schres.2012.08.034. Epub 2012 Sep 29.

17.

Randomized crossover study of the histamine H3 inverse agonist MK-0249 for the treatment of cognitive impairment in patients with schizophrenia.

F Egan M, Zhao X, Gottwald R, Harper-Mozley L, Zhang Y, Snavely D, Lines C, Michelson D.

Schizophr Res. 2013 May;146(1-3):224-30. doi: 10.1016/j.schres.2013.02.030. Epub 2013 Mar 22.

PMID:
23523692
18.

Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance on the Repeatable Battery for the Assessment of Neuropsychological Status.

Dickerson F, Boronow JJ, Stallings C, Origoni AE, Cole SK, Yolken RH.

Psychiatry Res. 2004 Nov 30;129(1):45-53.

PMID:
15572184
19.

The role of attention and immediate memory in vulnerability to interpersonal criticism during family transactions in schizophrenia.

Kéri S, Kelemen O.

Br J Clin Psychol. 2009 Mar;48(Pt 1):21-9. doi: 10.1348/014466508X342926. Epub 2008 Sep 11.

PMID:
18789188
20.

Association between DBH 19 bp insertion/deletion polymorphism and cognition in first-episode schizophrenic patients.

Hui L, Zhang X, Yu YQ, Han M, Huang XF, Chen da C, Wang ZR, Du WL, Kou CG, Yu Q, Kosten TR, Zhang XY.

Schizophr Res. 2013 Jul;147(2-3):236-40. doi: 10.1016/j.schres.2013.04.035. Epub 2013 May 23.

PMID:
23707643
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk